Iktos
Paris, FR · 3 known investors
Spaya is an AI-powered retrosynthesis platform that identifies synthetic routes to target compounds by converting them into commercially available starting materials. It serves chemists and drug discovery teams seeking to accelerate research through rapid, customizable synthesis planning.
Founders & leadership
Y
YannCo-founder and CEO
Q
QuentinCo-founder and CSO
N
NicolasCo-founder and CTO
Investors · 3
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AMar 2023 · 2 sources
Debiopharm Innovation Fund (lead), M Ventures (lead), Omnes Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 4
by search overlap
Altos Labs10 shared keywordsAltos Labs develops computational and scientific approaches to reverse disease through breakthrough medicines, operating research institutes focused on cell health, computation, and drug discovery.
ACTO9 shared keywordsActo provides a mobile app platform for field-based sales teams in regulated industries to deliver training, coaching, and presentations with approved content and messaging. The solution includes keyword search, knowledge tracking via surveys, and push notification alerts for content updates.
Pathos8 shared keywordsPathos applies AI, biological modeling, and a large collection of multimodal oncology patient data to develop cancer drugs and accelerate clinical development. It operates the PathOS platform with engines for asset selection, clinical trial execution, and an oncology foundation model.
Mytos8 shared keywordsMytos develops automated manufacturing technology for regenerative medicines, specifically targeting the production of stem cell-derived therapies to make treatments for conditions like Parkinson's, blindness, and spinal cord injury accessible and affordable to patients.
Companies competing with Iktos for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Iktos do?
- Spaya is an AI-powered retrosynthesis platform that identifies synthetic routes to target compounds by converting them into commercially available starting materials. It serves chemists and drug discovery teams seeking to accelerate research through rapid, customizable synthesis planning.
- Who founded Iktos?
- Iktos was founded by Yann, Quentin, Nicolas.
- Who are Iktos's investors?
- Iktos's investors include M Ventures, Debiopharm Innovation Fund, Omnes Capital.
- Where is Iktos headquartered?
- Iktos is headquartered in Paris, FR.